URBASHI ZAMAN: Open Payments
NPI 1457039950 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,392 in 61 payments from 14 companies in 2025. Trend: 2023 $162 · 2024 $1,479 · 2025 $1,392
Food & beverage: $1,392
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $322 |
| Collegium Pharmaceutical, Inc. | 14 | $233 |
| Stryker Corporation | 1 | $137 |
| Saluda Medical Americas, Inc. | 1 | $122 |
| PFIZER INC. | 4 | $121 |
| Lundbeck LLC | 5 | $109 |
| ABBVIE INC. | 4 | $75 |
| Electronic Waveform Lab, Inc. | 6 | $59 |
| Medtronic, Inc. | 1 | $59 |
| Tonix Medicines, Inc. | 2 | $50 |
Products named: RELISTOR, Belbuca, MILD DEVICE KIT, Evoke, NURTEC ODT, VYEPTI, XTAMPZA, QULIPTA.
Industry payments across MD — which companies pay providers there.
